MediPal Holdings Corporation (TYO:7459)

Japan · Delayed Price · Currency is JPY

2,933.50

-36.50 (-1.23%)

Feb 13, 2026, 2:35 PM JST

33.40% (1Y)

Market Cap	607.95B +25.7%
Revenue (ttm)	3.78T +3.4%
Net Income	41.46B -16.1%
EPS	200.64 -15.2%
Shares Out	204.70M
PE Ratio	14.80
Forward PE	16.37
Dividend	64.00 (2.16%)
Ex-Dividend Date	Mar 30, 2026

Volume	175,100
Average Volume	340,560
Open	2,950.00
Previous Close	2,970.00
Day's Range	2,917.00 - 2,978.50
52-Week Range	2,156.00 - 3,004.00
Beta	-0.10
RSI	65.03
Earnings Date	Feb 9, 2026

About MediPal Holdings

Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprising medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; and animal health product... [Read more]

Industry Medical Distribution

Sector Healthcare

Founded 1898

Employees 13,061

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 7459

Full Company Profile

Financial Performance

In fiscal year 2025, MediPal Holdings's revenue was 3.67 trillion, an increase of 3.16% compared to the previous year's 3.56 trillion. Earnings were 40.28 billion, a decrease of -2.88%.

Financial Statements